AXP
AirXpanders, Inc.
$0.031
Prices as at 16:40, 22 Mar 2019
AXP Current Share Price+
Current Price $0.031
Open $0.034
High $0.035
Low $0.031
Last Close $0.031
Volume 645524
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.
AXP General Information
AirXpanders, Inc.
AXP
http://www.airxpanders.com
Health Care Equipment
5
558
AXP
AirXpanders, Inc.
Current Price
$0.031 as at 16:40, 22 Mar 2019
Price at review
$0.031
AXP Company Overview
Business Description
AirXpanders, Inc (AXP) is a US based medical device company focused on the design, manufacturing, sale and distribution of its AeroForm tissue expander for breast reconstruction procedures following mastectomy. It was founded with the purpose of developing a better method for breast tissue expansion than traditional saline tissue expanders.
AXP Financial Summary
Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -37.86 -30.00 0.00% 0.00 0.00 0.00% 0.0%
2017 A -37.16 -11.00 0.00% 0.00 0.00 0.00% 0.0%
2016 A -26.84 -29.90 0.00% 0.00 0.00 0.00% 0.0%
AXP Peer Comparison
Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
AirXpanders (AXP) $19M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $10,198M 0.0828 0.1279 0.0999 41.9372 37.1815 33.8040 1.70% 1.84% 2.01%
Fisher & Paykel Hlth (FPH) $8,485M 0.1095 0.0519 0.1681 44.0966 41.9218 35.8893 1.35% 1.61% 1.92%
ResMed (RMD) $5,487M 0.2815 0.0552 0.1410 31.7001 30.0432 26.3297 1.38% 1.76% 2.02%
AXP Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 2.70 0.00
Market 0.68 14.90 1.19 1.12
Sector 0.85 17.50 1.71 3.00
AXP Directors
Name Position Start Date
Mr Francis (Frank) P Grillo Chief Executive Officer, Executive Director, President 12 Jun 2018
Mr Barry Cheskin Non-Executive Chairman, Non-Executive Director 29 Dec 2006
Ms Zita Peach Non-Executive Director 17 May 2016
Mr Dennis Edward Condon Non-Executive Director 1 Aug 2012
Mr Gregory Lichtwardt Non-Executive Director 17 May 2016
Ms Elizabeth Hammack Non-Executive Director 23 May 2017
AXP Management
Name Position
Brendan Case Company Secretary
Laurel Burk Director of Marketing
Gwen Drain Senior Director of Human Resources
Melissa Comunale VP of Sales
Tony Morefield VP, Operations
Mark Payne VP, R&D

AXP Substantial Shareholders

Holding Name
70,696,600 (24.56%) Citicorp Nominees Pty Limited
50,526,477 (17.55%) Vivo
44,804,359 (15.56%) GBS Venture Partners Pty Ltd as Trustee for the GBS Bioventures IV Trust
35,763,148 (12.43%) J P Morgan Nominees Australia Limited
24,740,731 (8.60%) Challenger Limited
24,504,900 (8.52%) Greencape Capital Pty Ltd
22,553,281 (7.84%) HSBC Custody Nominees (Australia) Limited
17,100,529 (5.94%) National Nominees Ltd
14,857,392 (5.16%) Regal Funds Management Pty Ltd
AXP Calendar of Events
Date Event
27 February 2020 Report (Annual)
27 February 2020 Report (Prelim)
30 August 2019 Report (Interim)
29 April 2019 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.